Citations

Citations to this article as recorded by  

• The Impact of GLP-1 RAs and DPP-4is on Hospitalisation and Mortality in the COVID-19 Era: A Two-Year Observational Study
  Salvatore Greco, Vincenzo M. Monda, Giorgia Valpiani, Nicola Napoli, Carlo Crespini, Fabio Pieraccini, Anna Marra, Angelina Passaro
  Biomedicines.2023; 11(8): 2292.     CrossRef
• Efficacy and Safety of Sitagliptin in the Treatment of COVID-19
  Ehab Mudher Mikhael, Siew Chin Ong, Siti Maisharah Sheikh Ghadzi
  Journal of Pharmacy Practice.2023; 36(4): 980.     CrossRef
• DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes
  Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Suprabhat Mukherjee, Rakesh Kundu
  Future Virology.2023; 18(5): 321.     CrossRef
• Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis
  Sabrina Schlesinger, Alexander Lang, Nikoletta Christodoulou, Philipp Linnerz, Kalliopi Pafili, Oliver Kuss, Christian Herder, Manuela Neuenschwander, Janett Barbaresko, Michael Roden
  Diabetologia.2023; 66(8): 1395.     CrossRef
• ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases
  Raquel Leão Neves, Jéssica Branquinho, Júlia Galanakis Arata, Clarissa Azevedo Bittencourt, Caio Perez Gomes, Michelle Riguetti, Gustavo Ferreira da Mata, Danilo Euclides Fernandes, Marcelo Yudi Icimoto, Gianna Mastroianni Kirsztajn, João Bosco Pesquero
  Inflammation Research.2023; 72(8): 1719.     CrossRef
• Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis
  Tiantian Han, Shaodi Ma, Chenyu Sun, Huimei Zhang, Guangbo Qu, Yue Chen, Ce Cheng, Eric L. Chen, Mubashir Ayaz Ahmed, Keun Young Kim, Raveena Manem, Mengshi Chen, Zhichun Guo, Hongru Yang, Yue Yan, Qin Zhou
  Archives of Medical Research.2022; 53(2): 186.     CrossRef
• Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong
  Carlos K.H. Wong, David T.W. Lui, Angel Y.C. Lui, Ashley C.Y. Kwok, Marshall C.H. Low, Kristy T.K. Lau, Ivan C.H. Au, Xi Xiong, Matthew S.H. Chung, Eric H.Y. Lau, Benjamin J. Cowling
  Diabetes & Metabolism.2022; 48(1): 101307.     CrossRef
• Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 — A systematic review and meta-analysis
  Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
  Primary Care Diabetes.2022; 16(1): 162.     CrossRef
• Mortality and Severity in COVID-19 Patients on ACEIs and ARBs—A Systematic Review, Meta-Analysis, and Meta-Regression Analysis
  Romil Singh, Sawai Singh Rathore, Hira Khan, Abhishek Bhurwal, Mack Sheraton, Prithwish Ghosh, Sohini Anand, Janaki Makadia, Fnu Ayesha, Kiran S. Mahapure, Ishita Mehra, Aysun Tekin, Rahul Kashyap, Vikas Bansal
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Short- and long-term prognosis of glycemic control in COVID-19 patients with type 2 diabetes
  K Zhan, X Zhang, B Wang, Z Jiang, X Fang, S Yang, H Jia, L Li, G Cao, K Zhang, X Ma
  QJM: An International Journal of Medicine.2022; 115(3): 131.     CrossRef
• Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients
  Ákos Nádasdi, György Sinkovits, Ilona Bobek, Botond Lakatos, Zsolt Förhécz, Zita Z Prohászka, Marienn Réti, Miklós Arató, Gellért Cseh, Tamás Masszi, Béla Merkely, Péter Ferdinandy, István Vályi-Nagy, Zoltán Prohászka, Gábor Firneisz
  Biomarkers in Medicine.2022; 16(5): 317.     CrossRef
• Management von Diabetespatienten in der COVID-19-Pandemie
  Charlotte Steenblock, Carlotta Hoffmann, Tilman D. Rachner, Florian Guggenbichler, Ermal Tahirukaj, Sacipi Bejtullah, Vsevolod A. Zinserling, Zsuzanna Varga, Stefan R. Bornstein, Nikolaos Perakakis
  Diabetes aktuell.2022; 20(01): 43.     CrossRef
• Letter: Diabesity Associates with Poor COVID-19 Outcomes among Hospitalized Patients (J Obes Metab Syndr 2021;30:149-54)
  Tae Jung Oh
  Journal of Obesity & Metabolic Syndrome.2022; 31(1): 86.     CrossRef
• Glucose-Lowering Agents and COVID-19
  Ah Reum Khang
  The Journal of Korean Diabetes.2022; 23(1): 1.     CrossRef
• The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis
  Yidan Chen, Xingfei Lv, Sang Lin, Mohammad Arshad, Mengjun Dai
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients
  Verena Schöning, Felix Hammann
  Pharmaceutics.2022; 14(9): 1828.     CrossRef
• Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
  Alba Sebastián-Martín, Belén G. Sánchez, José M. Mora-Rodríguez, Alicia Bort, Inés Díaz-Laviada
  Biomedicines.2022; 10(8): 2026.     CrossRef
• Anti-Diabetic Drugs GLP-1 Agonists and DPP-4 Inhibitors may Represent Potential Therapeutic Approaches for COVID-19
  Aliah Alshanwani, Tarek Kashour, Amira Badr
  Endocrine, Metabolic & Immune Disorders - Drug Targets.2022; 22(6): 571.     CrossRef
• Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control
  Niya Narayanan, Dukhabandhu Naik, Jayaprakash Sahoo, Sadishkumar Kamalanathan
  World Journal of Virology.2022; 11(6): 399.     CrossRef
• Associations Between the Use of Renin–Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies
  Xiao-Ce Dai, Zhuo-Yu An, Zi-Yang Wang, Zi-Zhen Wang, Yi-Ren Wang
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
  Sabrina Schlesinger, Manuela Neuenschwander, Alexander Lang, Kalliopi Pafili, Oliver Kuss, Christian Herder, Michael Roden
  Diabetologia.2021; 64(7): 1480.     CrossRef
• Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications
  Mariana Alves, Marília Andreia Fernandes, Gülistan Bahat, Athanase Benetos, Hugo Clemente, Tomasz Grodzicki, Manuel Martínez-Sellés, Francesco Mattace-Raso, Chakravarthi Rajkumar, Andrea Ungar, Nikos Werner, Timo E. Strandberg, Grodzicki, Strandberg
  European Geriatric Medicine.2021; 12(4): 725.     CrossRef
• Cardiometabolic Therapy and Mortality in Very Old Patients With Diabetes Hospitalized due to COVID-19
  Jose Manuel Ramos-Rincón, Luis M Pérez-Belmonte, Francisco Javier Carrasco-Sánchez, Sergio Jansen-Chaparro, Mercedes De-Sousa-Baena, José Bueno-Fonseca, Maria Pérez-Aguilar, Coral Arévalo-Cañas, Marta Bacete Cebrian, Manuel Méndez-Bailón, Isabel Fiteni Me
  The Journals of Gerontology: Series A.2021; 76(8): e102.     CrossRef
• Managing diabetes in diabetic patients with COVID: where do we start from?
  Angelo Avogaro, Benedetta Bonora, Gian Paolo Fadini
  Acta Diabetologica.2021; 58(11): 1441.     CrossRef
• The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in myalgic encephalomyelitis/chronic fatigue syndrome: A meta-analysis of public DNA methylation and gene expression data
  João Malato, Franziska Sotzny, Sandra Bauer, Helma Freitag, André Fonseca, Anna D. Grabowska, Luís Graça, Clara Cordeiro, Luís Nacul, Eliana M. Lacerda, Jesus Castro-Marrero, Carmen Scheibenbogen, Francisco Westermeier, Nuno Sepúlveda
  Heliyon.2021; 7(8): e07665.     CrossRef
• Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)
  Sang Youl Rhee
  Diabetes & Metabolism Journal.2021; 45(4): 619.     CrossRef
• Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)
  Guntram Schernthaner
  Diabetes & Metabolism Journal.2021; 45(4): 615.     CrossRef
• COVID-19 and metabolic disease: mechanisms and clinical management
  Charlotte Steenblock, Peter E H Schwarz, Barbara Ludwig, Andreas Linkermann, Paul Zimmet, Konstantin Kulebyakin, Vsevolod A Tkachuk, Alexander G Markov, Hendrik Lehnert, Martin Hrabě de Angelis, Hannes Rietzsch, Roman N Rodionov, Kamlesh Khunti, David Hop
  The Lancet Diabetes & Endocrinology.2021; 9(11): 786.     CrossRef
• Diabetes, Obesity, and COVID-19
  Sang Youl Rhee
  The Journal of Korean Diabetes.2021; 22(3): 174.     CrossRef
• Sunlight Exposure and Phototherapy: Perspectives for Healthy Aging in an Era of COVID-19
  Toshiaki Nakano, Kuei-Chen Chiang, Chien-Chih Chen, Po-Jung Chen, Chia-Yun Lai, Li-Wen Hsu, Naoya Ohmori, Takeshi Goto, Chao-Long Chen, Shigeru Goto
  International Journal of Environmental Research and Public Health.2021; 18(20): 10950.     CrossRef
• Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-
  E. I. Tarlovskaya, A. G. Arutyunov, A. O. Konradi, Yu. M. Lopatin, A. P. Rebrov, S. N. Tereshchenko, A. I. Chesnikova, H. G. Hayrapetyan, A. P. Babin, I. G. Bakulin, N. V. Bakulina, L. A. Balykova, A. S. Blagonravova, M. V. Boldina, A. R. Vaisberg, A. S.
  Kardiologiia.2021; 61(9): 20.     CrossRef
• Association of clinical characteristics, antidiabetic and cardiovascular agents with diabetes mellitus and COVID-19: a 7-month follow-up cohort study
  Marzieh Pazoki, Fatemeh Chichagi, Azar Hadadi, Samira Kafan, Mahnaz Montazeri, Sina Kazemian, Arya Aminorroaya, Mehdi Ebrahimi, Haleh Ashraf, Mojgan Mirabdolhagh Hazaveh, Mohammad Reza Khajavi, Reza Shariat Moharari, Seyed Hamidreza Sharifnia, Shahrokh Ka
  Journal of Diabetes & Metabolic Disorders.2021; 20(2): 1545.     CrossRef
• COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy
  Lingli Xie, Ziying Zhang, Qian Wang, Yangwen Chen, Dexue Lu, Weihua Wu
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
  Tianli Zhang, Xiang Tong, Shijie Zhang, Dongguang Wang, Lian Wang, Qian Wang, Hong Fan
  Frontiers in Pharmacology.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Digital Health in Diabetes and Cardiovascular Disease
  Dorothy Avoke, Abdallah Elshafeey, Robert Weinstein, Chang H. Kim, Seth S. Martin
  Endocrine Research.2024; : 1.     CrossRef
• Weight Management Health Note, a Mobile Health Platform for Obesity Management Developed by the Korean Society for the Study of Obesity
  Yujung Lee, Hyunji Sang, Sunyoung Kim, Doo Ah Choi, Sang Youl Rhee
  Journal of Obesity & Metabolic Syndrome.2024; 33(1): 1.     CrossRef
• Effectiveness of a Social Networking Site Based Automatic Mobile Message Providing System on Glycemic Control in Patients with Type 2 Diabetes Mellitus
  Kyuho Kim, Jae-Seung Yun, Joonyub Lee, Yeoree Yang, Minhan Lee, Yu-Bae Ahn, Jae Hyoung Cho, Seung-Hyun Ko
  Endocrinology and Metabolism.2024; 39(2): 344.     CrossRef
• A data-driven approach to manage type 2 diabetes mellitus through digital health: The Klivo Intervention Program protocol (KIPDM)
  Camila Maciel de Oliveira, Luiza Borcony Bolognese, Mercedes Balcells, Davi Casale Aragon, Roberto Luis Zagury, Clemente Nobrega, Chunyu Liu, Dured Dardari
  PLOS ONE.2023; 18(2): e0281844.     CrossRef
• Public Health Framework for Smart Cities within the Comprehensive Approach to Sustainability in Europe: Case Study of Diabetes
  Luís Velez Lapão, Jorge César Correia, Marija Jevtic
  Sustainability.2023; 15(5): 4269.     CrossRef
• Lessons for Vietnam on the Use of Digital Technologies to Support Patient-Centered Care in Low- and Middle-Income Countries in the Asia-Pacific Region: Scoping Review
  Leona Kosowicz, Kham Tran, Toan Tran Khanh, Thu Ha Dang, Van An Pham, Hue Ta Thi Kim, Hoang Thi Bach Duong, Tran Dong Nguyen, Anh Tuyet Phuong, Trong Hieu Le, Van Anh Ta, Nilmini Wickramasinghe, Penelope Schofield, John Zelcer, Tuan Pham Le, Tuan Anh Nguy
  Journal of Medical Internet Research.2023; 25: e43224.     CrossRef
• Digital health, cardiometabolic disease and ethnicity: an analysis of United Kingdom government policies from 2010 to 2022
  Zareen Thorlu-Bangura, Lydia Poole, Harpreet Sood, Nushrat Khan, Fiona Stevenson, Kamlesh Khunti, Paramjit Gill, Madiha Sajid, Wasim Hanif, Neeraj Bhala, Shivali Modha, Kiran Patel, Ann Blandford, Amitava Banerjee, Mel Ramasawmy
  Journal of Public Health Policy.2023; 44(2): 179.     CrossRef
• Digital Behavior Change Interventions to Reduce Sedentary Behavior and Promote Physical Activity in Adults with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Xiaoyan Zhang, Xue Qiao, Ke Peng, Shan Gao, Yufang Hao
  International Journal of Behavioral Medicine.2023;[Epub]     CrossRef
• Exploring the underlying mechanisms of obesity and diabetes and the potential of Traditional Chinese Medicine: an overview of the literature
  Yan-kun Chen, Ting-ting Liu, Farah Khameis Farag Teia, Meng-zhou Xie
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Stakeholders’ Perceptions Regarding Digital Therapeutics Reimbursement in South Korea: Qualitative Study
  Boram Sim, Jin Han Ju, Byungsoo Kim, Jin Yong Lee
  JMIR mHealth and uHealth.2023; 11: e47407.     CrossRef
• Research Trends in Motivation and Weight Loss: A Bibliometric-Based Review
  Uroš Železnik, Peter Kokol, Jasmina Starc, Danica Železnik, Jernej Završnik, Helena Blažun Vošner
  Healthcare.2023; 11(23): 3086.     CrossRef
• Analysis of the management and therapeutic performance of diabetes mellitus employing special target
  Hong-Yan Sun, Xiao-Yan Lin
  World Journal of Diabetes.2023; 14(12): 1721.     CrossRef
• Psychoeducational Interventions in Children and Adolescents with Type-1 Diabetes: A Systematic Review
  Bárbara Luque, Joaquín Villaécija, Rosario Castillo-Mayén, Esther Cuadrado, Sebastián Rubio, Carmen Tabernero
  Clínica y Salud.2022; 33(1): 35.     CrossRef
• Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19
  Mei Zhang, Xiaoxia Zhu, Jing Wu, Zhengjing Huang, Zhenping Zhao, Xiao Zhang, Yu Xue, Weiguo Wan, Chun Li, Wenrong Zhang, Linhong Wang, Maigeng Zhou, Hejian Zou, Limin Wang
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Blood Pressure Monitoring as a Digital Health Tool for Improving Diabetes Clinical Outcomes: Retrospective Real-world Study
  ‪Yifat Fundoiano-Hershcovitz, Dror Bacher, Marilyn D Ritholz, David L Horwitz, Omar Manejwala, Pavel Goldstein
  Journal of Medical Internet Research.2022; 24(2): e32923.     CrossRef
• The effectiveness of a structured group education programme for people with established type 2 diabetes in a multi-ethnic population in primary care: A cluster randomised trial
  Helen Dallosso, Panna Mandalia, Laura J. Gray, Yogini V. Chudasama, Sopna Choudhury, Shahrad Taheri, Naina Patel, Kamlesh Khunti, Melanie J. Davies
  Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(6): 1549.     CrossRef
• Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record–Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial
  Eun Young Lee, Seon-Ah Cha, Jae-Seung Yun, Sun-Young Lim, Jin-Hee Lee, Yu-Bae Ahn, Kun-Ho Yoon, Min Kyung Hyun, Seung-Hyun Ko
  Journal of Medical Internet Research.2022; 24(7): e37430.     CrossRef
• Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus—a study protocol
  Noor Suleiman, Meis Alkasem, Zaina Al Amer, Obada Salameh, Noora Al-Thani, Mohammad Khair Hamad, Khaled Baagar, Ibrahem Abdalhakam, Manal Othman, Ragae Dughmosh, Dabia Al-Mohanadi, Ali Al Sanousi, Mohammed Bashir, Odette Chagoury, Shahrad Taheri, Abdul-Ba
  Trials.2022;[Epub]     CrossRef
• Digital environment: An evolutionary component in environmental health
  Afiqah Syamimi Masrani, Nik Rosmawati Nik Husain
  Journal of Public Health Research.2022; 11(2): 227990362211031.     CrossRef
• Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic
  Lavanya Kondapalli, Garima Arora, Riem Hawi, Efstathia Andrikopoulou, Courtney Estes, Nirav Patel, Carrie G. Lenneman
  Current Treatment Options in Oncology.2022; 23(9): 1288.     CrossRef
• Effects of peer support and mobile application-based walking programme on physical activity and physical function in rural older adults: a cluster randomized controlled trial
  Xue Cai, Shanhu Qiu, Dan Luo, Ruxue Li, Chengyu Liu, Yanhui Lu, Cuirong Xu, Mingzi Li
  European Geriatric Medicine.2022; 13(5): 1187.     CrossRef

Citations

Citations to this article as recorded by  

• Continuity of primary care for type 2 diabetes and hypertension and its association with health outcomes and disease control: insights from Central Vietnam
  Quynh-Anh Le Ho Thi, Peter Pype, Johan Wens, Huy Nguyen Vu Quoc, Anselme Derese, Wim Peersman, Nhon Bui, Huyen Nguyen Thi Thanh, Tam Nguyen Minh
  BMC Public Health.2024;[Epub]     CrossRef
• Application of continuing nursing intervention on wound infection and ulcers in patients with diabetic foot: A meta‐analysis
  Xu‐Xiang Li, Jing Xu, Juan Chen, Feng Gao, Qing‐Ju Wang, Shi‐Hu Yang
  International Wound Journal.2024;[Epub]     CrossRef
• Impact of the family doctor system on the continuity of care for diabetics in urban China: a difference-in-difference analysis
  Xinyi Liu, Luying Zhang, Wen Chen
  BMJ Open.2023; 13(2): e065612.     CrossRef
• The associations of continuity of care with inpatient, outpatient, and total medical care costs among older adults with urinary incontinence
  Eunkyung Han, Wankyo Chung, Antonio Trujillo, Joel Gittelsohn, Leiyu Shi
  BMC Health Services Research.2023;[Epub]     CrossRef
• Association between initial continuity of care status and diabetes-related health outcomes in older patients with type 2 diabetes mellitus: A nationwide retrospective cohort study in South Korea
  Hyun Woo Jung, Woo-Ri Lee
  Primary Care Diabetes.2023; 17(6): 600.     CrossRef
• Relationship between continuity of care and clinical outcomes in patients with dyslipidemia in Korea: a real world claims database study
  Juhee Lee, Eunyoung Choi, Eunjung Choo, Siachalinga Linda, Eun Jin Jang, Iyn-Hyang Lee
  Scientific Reports.2022;[Epub]     CrossRef
• Association Between Team-Based Continuity of Care and Risk of Cardiovascular Diseases Among Patients With Diabetes: A Retrospective Cohort Study
  Kam Suen Chan, Eric Yuk Fai Wan, Weng Yee Chin, Esther Yee Tak Yu, Ivy Lynn Mak, Will Ho Gi Cheng, Margaret Kay Ho, Cindy Lo Kuen Lam
  Diabetes Care.2022; 45(5): 1162.     CrossRef
• Personal continuity of GP care and outpatient specialist visits in people with type 2 diabetes: A cross-sectional survey
  Anne Helen Hansen, May-Lill Johansen, Dylan A. Mordaunt
  PLOS ONE.2022; 17(10): e0276054.     CrossRef
• Clinical Study Using Healthcare Claims Database
  Jin-Su Park, Chan Hee Lee
  Journal of Rheumatic Diseases.2021; 28(3): 119.     CrossRef
• Effects of continuity of care on health outcomes among patients with diabetes mellitus and/or hypertension: a systematic review
  Kam-Suen Chan, Eric Yuk-Fai Wan, Weng-Yee Chin, Will Ho-Gi Cheng, Margaret Kay Ho, Esther Yee-Tak Yu, Cindy Lo-Kuen Lam
  BMC Family Practice.2021;[Epub]     CrossRef
• Young-onset type 2 diabetes in South Korea: a review of the current status and unmet need
  Ye Seul Yang, Kyungdo Han, Tae Seo Sohn, Nam Hoon Kim
  The Korean Journal of Internal Medicine.2021; 36(5): 1049.     CrossRef